FAS and acute lymphoblastic leukemia: In fact, impaired CD95 signaling has been implicated in many pediatric haemopoietic malignancies, including childhood acute leukemias (ALL and AML) and B-cell non-Hodgkin lymphomas (NHLs) [29,30,31].